Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis

Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis

Objectives: With an increasing number of disease-modifying treatments (DMTs) for multiple sclerosis (MS), patient preferences will gain importance in the decision-making process. We assessed patients’ implicit preferences for oral versus parenteral DMTs and identified factors influencing patients’ t...

Full description

Bibliographic Details
Main Authors: Kathrin S. Utz, Jana Hoog, Andreas Wentrup, Sebastian Berg, Alexandra Lämmer, Britta Jainsch, Anne Waschbisch, De-Hyung Lee, Ralf A. Linker, Thomas Schenk
Format: Article
Language:English
Published: SAGE Publishing 2014-11-01
Series:Therapeutic Advances in Neurological Disorders
Online Access:https://doi.org/10.1177/1756285614555335

Similar Items

Similar Items